Sexual function in patients with cancer
The impairments induced by surgery, chemotherapy or
radiation for cancer treatment on sexual function and
fertility need to be discussed with every patient.
In younger patients, ceasing ovarian function and loss of
fertility are the main concerns,for postmenopausal women
probably the loss of the remaining androgen activity of
the postmenopausal ovary plays an important role.
Physicians should be aware that sexuality is an important
quality of life factor and should therefore discuss possible
treatment side effects with the patient.
From an oncological point of view, local or even systemic
estrogens can be considered as safe for most of the gynecologic
oncology patients. Besides local therapies,physical
therapy and exercise are supportive.
Treatment side effects on fertility depend on the patient's
age, stage of disease, the choice of chemotherapeutic
agents or radiation therapy, and finally on the individual's
sensitivity of the ovary.Information about different options
for fertility protection and contact data of fertility centers
can be obtained from the network FertiPROTECT
CME Prakt Fortbild Gynakol Geburtsmed Gynakol
Endokrinol 2009; 5(3): 220-230
Sexual function, fertility protection, cancer, estrogens
Juliane Farthmann, Annette Hasenburg
Reviewer: Nicole Gehrmann, Berlin
und Alexandra Coumbos,Hamburg
Farthmann J. Sexualität ... Gynakol Geburtsmed Gynakol Endokrinol 2009;5(3): 220-230 publiziert 30.11.09 www.akademos.de/gyn ©akademos Wissenschaftsverlag 2009 ISSN 1614-8533